FDA Inspection 1053164 — Sanjeev Sharma, M.D
The FDA completed an inspection of Sanjeev Sharma, M.D on May 10, 2018 in Oceanside, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 10, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oceanside, CA (United States)
Additional Details
Clinical Investigator (CI)